Finance

Lists
002755:SHE
Beijing Aosaikang Pharmaceutical Co Ltd
CNÂ¥11.70
+2.09%
(+0.24) 1D
Sep 4, 3:04:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002755...
Open
CNÂ¥11.48
High
CNÂ¥12.15
Low
CNÂ¥11.43
Mkt. cap
10.58B
Avg. vol.
12.93M
Volume
17.07M
Dividend
1.03%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jun 18, 2026
P/E ratio
55.05
52-wk high
CNÂ¥23.80
52-wk low
CNÂ¥11.26
EPS
CNÂ¥0.21
Shares outstanding
928.16M
No. of employees
799
Open
CNÂ¥11.48
High
CNÂ¥12.15
Low
CNÂ¥11.43
Mkt. cap
10.58B
Avg. vol.
12.93M
Volume
17.07M
Dividend
1.03%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jun 18, 2026
P/E ratio
55.05
52-wk high
CNÂ¥23.80
52-wk low
CNÂ¥11.26
EPS
CNÂ¥0.21
Shares outstanding
928.16M
No. of employees
799
About Beijing Aosaikang Pharmaceutical Co Ltd
CEO-
Employees799
FoundedDec 24, 1996
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
426.48M
345.13M
481.78M
389.27M
Cost of goods sold
104.64M
63.62M
76.60M
80.08M
Cost of revenue
104.64M
63.62M
76.60M
80.08M
Research and development expenses
24.80M
43.39M
26.24M
120.77M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
245.93M
211.23M
271.28M
158.63M
Operating expense
240.44M
295.08M
300.50M
286.52M
Total operating expenses
345.08M
358.70M
377.10M
366.59M
Operating income
81.40M
-13.57M
104.68M
22.67M
Other non operating income
936.04K
1.76M
273.08K
-1.29M
EBT including unusual items
64.12M
38.49M
112.80M
34.94M
EBT excluding unusual items
80.66M
-7.60M
108.10M
27.24M
Income tax expense
3.90M
32.42M
8.92M
5.98M
Effective tax rate
6.08%
84.22%
7.91%
17.12%
Other operating expenses
-29.70M
40.68M
5.15M
4.16M
Net income
63.33M
13.29M
84.47M
36.16M
Net profit margin
14.85%
3.85%
17.53%
9.29%
Earnings per share
-
-
-
-
Interest and investment income
-
3.63M
4.33M
6.42M
Interest expense
-1.05M
-99.07K
-1.18M
-
Net interest expenses
-1.05M
3.53M
3.15M
6.42M
Depreciation and amortization charges
-
-
-
-
EBITDA
100.22M
17.89M
136.14M
54.31M
Gain or loss from assets sale
-
27.23K
-
383.90K
AI content may include mistakes. Learn more
Google apps